These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

980 related articles for article (PubMed ID: 32979942)

  • 1. Molecular Architecture of the SARS-CoV-2 Virus.
    Yao H; Song Y; Chen Y; Wu N; Xu J; Sun C; Zhang J; Weng T; Zhang Z; Wu Z; Cheng L; Shi D; Lu X; Lei J; Crispin M; Shi Y; Li L; Li S
    Cell; 2020 Oct; 183(3):730-738.e13. PubMed ID: 32979942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET.
    Liu C; Mendonça L; Yang Y; Gao Y; Shen C; Liu J; Ni T; Ju B; Liu C; Tang X; Wei J; Ma X; Zhu Y; Liu W; Xu S; Liu Y; Yuan J; Wu J; Liu Z; Zhang Z; Liu L; Wang P; Zhang P
    Structure; 2020 Nov; 28(11):1218-1224.e4. PubMed ID: 33058760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography.
    Klein S; Cortese M; Winter SL; Wachsmuth-Melm M; Neufeldt CJ; Cerikan B; Stanifer ML; Boulant S; Bartenschlager R; Chlanda P
    Nat Commun; 2020 Nov; 11(1):5885. PubMed ID: 33208793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress.
    Mendonça L; Howe A; Gilchrist JB; Sheng Y; Sun D; Knight ML; Zanetti-Domingues LC; Bateman B; Krebs AS; Chen L; Radecke J; Li VD; Ni T; Kounatidis I; Koronfel MA; Szynkiewicz M; Harkiolaki M; Martin-Fernandez ML; James W; Zhang P
    Nat Commun; 2021 Jul; 12(1):4629. PubMed ID: 34330917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein.
    Tai L; Zhu G; Yang M; Cao L; Xing X; Yin G; Chan C; Qin C; Rao Z; Wang X; Sun F; Zhu Y
    Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34782481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
    Fan X; Cao D; Kong L; Zhang X
    Nat Commun; 2020 Jul; 11(1):3618. PubMed ID: 32681106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
    Wrobel AG; Benton DJ; Xu P; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Struct Mol Biol; 2020 Aug; 27(8):763-767. PubMed ID: 32647346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of an early SARS-CoV-2 isolate from the 2020 epidemic in Medellín, Colombia.
    Díaz FJ; Aguilar-Jiménez W; Flórez-Álvarez L; Valencia G; Laiton-Donato K; Franco-Muñoz C; Álvarez-Díaz D; Mercado-Reyes M; Rugeles MT
    Biomedica; 2020 Oct; 40(Supl. 2):148-158. PubMed ID: 33152198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.
    Song W; Gui M; Wang X; Xiang Y
    PLoS Pathog; 2018 Aug; 14(8):e1007236. PubMed ID: 30102747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.
    Wrobel AG; Benton DJ; Hussain S; Harvey R; Martin SR; Roustan C; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Commun; 2020 Oct; 11(1):5337. PubMed ID: 33087721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of SARS-CoV-2 Isolated from Asymptomatic Carriers in Tokyo.
    Nagashima M; Kumagai R; Yoshida I; Kawakami M; Nagano M; Asakura H; Kaku E; Kitamura Y; Hasegawa M; Hayashi Y; Chiba T; Sadamasu K; Yoshimura K
    Jpn J Infect Dis; 2020 Jul; 73(4):320-322. PubMed ID: 32350227
    [No Abstract]   [Full Text] [Related]  

  • 13. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
    Yurkovetskiy L; Wang X; Pascal KE; Tomkins-Tinch C; Nyalile TP; Wang Y; Baum A; Diehl WE; Dauphin A; Carbone C; Veinotte K; Egri SB; Schaffner SF; Lemieux JE; Munro JB; Rafique A; Barve A; Sabeti PC; Kyratsous CA; Dudkina NV; Shen K; Luban J
    Cell; 2020 Oct; 183(3):739-751.e8. PubMed ID: 32991842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.
    Zhou D; Duyvesteyn HME; Chen CP; Huang CG; Chen TH; Shih SR; Lin YC; Cheng CY; Cheng SH; Huang YC; Lin TY; Ma C; Huo J; Carrique L; Malinauskas T; Ruza RR; Shah PNM; Tan TK; Rijal P; Donat RF; Godwin K; Buttigieg KR; Tree JA; Radecke J; Paterson NG; Supasa P; Mongkolsapaya J; Screaton GR; Carroll MW; Gilbert-Jaramillo J; Knight ML; James W; Owens RJ; Naismith JH; Townsend AR; Fry EE; Zhao Y; Ren J; Stuart DI; Huang KA
    Nat Struct Mol Biol; 2020 Oct; 27(10):950-958. PubMed ID: 32737466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.
    Boson B; Legros V; Zhou B; Siret E; Mathieu C; Cosset FL; Lavillette D; Denolly S
    J Biol Chem; 2021; 296():100111. PubMed ID: 33229438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-Native Visualization of SARS-CoV-2 Induced Membrane Remodeling and Virion Morphogenesis.
    Bergner T; Zech F; Hirschenberger M; Stenger S; Sparrer KMJ; Kirchhoff F; Read C
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
    Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
    Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.
    Toelzer C; Gupta K; Yadav SKN; Borucu U; Davidson AD; Kavanagh Williamson M; Shoemark DK; Garzoni F; Staufer O; Milligan R; Capin J; Mulholland AJ; Spatz J; Fitzgerald D; Berger I; Schaffitzel C
    Science; 2020 Nov; 370(6517):725-730. PubMed ID: 32958580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
    Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
    Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
    Benton DJ; Wrobel AG; Roustan C; Borg A; Xu P; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33579792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.